These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 26985892)

  • 1. Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease.
    Ban LA; Shackel NA; McLennan SV
    Int J Mol Sci; 2016 Mar; 17(3):376. PubMed ID: 26985892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy.
    Hernández A; Arab JP; Reyes D; Lapitz A; Moshage H; Bañales JM; Arrese M
    Cells; 2020 Mar; 9(4):. PubMed ID: 32231001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of detection of extracellular vesicles in the diagnosis of nonalcoholic fatty liver disease].
    Jiang WY; Xun YH
    Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):92-96. PubMed ID: 32023709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights Into Extracellular Vesicles as Biomarker of NAFLD Pathogenesis.
    Garcia-Martinez I; Alen R; Rada P; Valverde AM
    Front Med (Lausanne); 2020; 7():395. PubMed ID: 32850903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.
    Zhu Q; Li H; Ao Z; Xu H; Luo J; Kaurich C; Yang R; Zhu PW; Chen SD; Wang XD; Tang LJ; Li G; Huang OY; Zheng MH; Li HP; Liu F
    J Nanobiotechnology; 2022 Jul; 20(1):349. PubMed ID: 35897102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH-Future Horizons in NASH Management.
    Trifylli EM; Kriebardis AG; Koustas E; Papadopoulos N; Deutsch M; Aloizos G; Fortis SP; Papageorgiou EG; Tsagarakis A; Manolakopoulos S
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets.
    Eguchi A; Iwasa M; Nakagawa H
    Liver Int; 2023 Feb; 43(2):292-298. PubMed ID: 36462157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update.
    Dorairaj V; Sulaiman SA; Abu N; Abdul Murad NA
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles as Inflammatory Drivers in NAFLD.
    Srinivas AN; Suresh D; Santhekadur PK; Suvarna D; Kumar DP
    Front Immunol; 2020; 11():627424. PubMed ID: 33603757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-Alcoholic Fatty Liver Disease.
    Garcia NA; Mellergaard M; Gonzalez-King H; Salomon C; Handberg A
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
    Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
    World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Extracellular Vesicles in the Pathophysiology, Diagnosis and Tracking of Non-Alcoholic Fatty Liver Disease.
    Newman LA; Sorich MJ; Rowland A
    J Clin Med; 2020 Jun; 9(7):. PubMed ID: 32610455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of extracellular vesicles in nonalcoholic fatty liver disease.
    Jiang W; Xu Y; Chen JC; Lee YH; Hu Y; Liu CH; Chen E; Tang H; Zhang H; Wu D
    Front Endocrinol (Lausanne); 2023; 14():1196831. PubMed ID: 37534206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis and treatment of non-alcoholic fatty liver disease.
    Altinbas A; Sowa JP; Hasenberg T; Canbay A
    Minerva Gastroenterol Dietol; 2015 Sep; 61(3):159-69. PubMed ID: 26080905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver fibrosis markers of nonalcoholic steatohepatitis.
    Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
    World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.
    Povero D; Eguchi A; Li H; Johnson CD; Papouchado BG; Wree A; Messer K; Feldstein AE
    PLoS One; 2014; 9(12):e113651. PubMed ID: 25470250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases.
    Shabangu CS; Huang JF; Hsiao HH; Yu ML; Chuang WL; Wang SC
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
    Muñoz-Hernández R; Gato S; Gil-Gómez A; Aller R; Rojas A; Morán L; Gallego J; Blázquez-López E; Gallego-Durán R; Montero-Vallejo R; García-Fernández V; Maya-Miles D; Rico MDC; Cubero FJ; Vaquero J; Ampuero J; Bañares R; Romero-Gómez M
    Liver Int; 2023 Sep; 43(9):1909-1919. PubMed ID: 37288714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver fibrosis in non-alcoholic fatty liver disease - diagnostic challenge with prognostic significance.
    Stål P
    World J Gastroenterol; 2015 Oct; 21(39):11077-87. PubMed ID: 26494963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.